vimarsana.com
Home
Live Updates
Pfizer snaps up migraine drugmaker Biohaven for $11.6bn : vi
Pfizer snaps up migraine drugmaker Biohaven for $11.6bn : vi
Pfizer snaps up migraine drugmaker Biohaven for $11.6bn
Acquiring Biohaven is Pfizer’s biggest deal in years and will allow the company to commercialise the Nurtec medication for migraine attacks.
Related Keywords
New Haven ,
Connecticut ,
United States ,
Nick Lagunowich ,
Pfizer ,
Reuters ,
Acquiring Biohaven ,
Pfizer Internal ,